Connect with us
In 2024, Europe and Spain advanced strategic biotechnology legislation, reinforcing biotech as key to economic growth and autonomy. Spain’s biotech sector grew, generating €13B in revenue...
Galicia has approved a €15.6 million investment to supply gene therapy for hemophilia B, becoming the first region in Spain to do so. The therapy, Etranacogene...
A BioSim study highlights biosimilars’ crucial role in reducing Spain’s healthcare spending, projecting €22.27 billion in savings from 2024–2030. Despite rising biologic drug costs, biosimilars ensure...
SpliceBio raised $135 million in a Series B round led by EQT Life Sciences and Sanofi Ventures, with support from major biotech investors. The funding will...
3A Biotech introduces Tocotyrosol and Bioprotec RT—natural, multifunctional ingredients enhancing food stability, safety, and health. Tocotyrosol offers antioxidant and health benefits, while Bioprotec RT provides antimicrobial...
María Río (Gilead) and Marina Pollán (ISCIII) formalized the 12th Gilead Biomedical Research Grants, Spain’s top pharma-sponsored R&D initiative. It supports HIV, oncology, and now PrEP...
Researchers developed a highly sensitive (99%) liquid biopsy blood test to detect HPV-related head and neck cancers. By identifying circulating tumor DNA post-surgery, it enables early...
Researchers developed CAR-STAb, a new immunotherapy combining CAR-T cells and bispecific antibodies, showing promise against B-cell malignancies in animal models. It recruits additional immune cells, blocking...
Spain’s health ministry has approved funding for Tofersen (Qalsody), the first EU-approved drug targeting a genetic cause of ALS—SOD1 mutations. This personalized therapy silences the gene...
Barcelona hosts the KRAS Think Tank Meeting, uniting global experts to share cutting-edge research on the KRAS oncogene, mutated in many cancers. Led by Dr. Rafael...
 |
|
 |  |
 |
|